Academic Rank:
Clinical Assistant Professor, UBC
Hematopathologist, Vancouver General Hospital
Affiliation(s):
Vancouver General Hospital
Short Bio:

Twitter: @KristaMarcon

You might say Pathology is in my blood. I was born and raised in Sudbury, Ontario by a Blood Bank Technologist (mother) and cytotechnologist (father). I came to beautiful British Columbia for University, and fell in love with Pathology during my Bachelor of Medical Laboratory Science (BMLSc.) program. Following my undergraduate program, I worked for a year as an immunohistochemistry technologist at the Genetic Pathology Evaluation Centre (GPEC) and decided to pursue medical school.  Throughout my medical school career I was drawn not only to Pathology, but came to love learning about hematology as well. I decided to marry the two interests and pursue a career in Hematological Pathology. While in residency training, I pursued extra training in laboratory quality management and completed the UBC POLQM Laboratory Quality Management Certificate course.  Following residency, I joined the VGH division of Hematopathology. My interests lie in quality improvement and utilization management.

Academic background

  • Master of Science in Healthcare Quality, Queen’s University 2020-2022
  • Hematological Pathology Residency, University of British Columbia 2019
  • Doctor of Medicine, University of British Columbia 2013
  • Bachelor of Medical Laboratory Science (BMLSc), UBC 2008

Publications

Dehghan N, Marcon K, Sedic T, Dutz JP, Beck DB, Chen LYC “Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: fevers, myalgia, arthralgia, auricular chondritis, and erythema nodosum.” The Lancet. Volume 398, Issue 10300 (2021): 621.
 
McGinnis E, Guo RJ, Marcon K, Berry B, Coupland R, Meneghetti V, Morrison D, Onell R, Steele L, Trudeau J, Wong M, Shih AW. “Adaptations of transfusion systems to the COVID-19 pandemic in British Columbia, Canada: early experiences of a large tertiary care center and survey of provincial activities”. Transfusion (2021). 
 
Al Moosawi, M., Marcon, K. “Bone marrow involvement by CD1a-negative langerhans cell histiocytosis with associated hemophagocytosis”. Int J Hematol (2021). 
 
Gauiran DTV, Marcon K, DeMarco ML, Fung AWS, van der Gugten G, Mattman A, Carruthers MN, Song KW, Chen LYC. “IgG4 plasma cell myeloma without clinical evidence of IgG4-related disease: a report of two cases.” Hematology, Volume 25, Issue 1 (2020): 335-340.

Kalloger SE, Kobel M, Leung S, Mehl E, Gao D, Marcon K, Chow C, Clark BA, Huntsman DG, Gilks CB. “Calculator for ovarian carcinoma subtype prediction.” Modern Pathology. Volume 24, Issue 4 (2011): 512-521.
 

Abstracts/Oral Presentations:

Hutspardol S, Boyd L, Sham L, Kalar D, Marcon K, Shih A. “The impacts of a new antibody investigation algorithm on reducing in false-positive warm autoantibody detection at a tertiary care centre in British Columbia, Canada” 
Oral Abstract – International Society of Blood Transfusion Conference – 2022
 
Clark A, Czapala C, Fong A, Marcon K. Improving Transfusion Reaction Reporting at Vancouver General Hospital – A Quality Improvement Initiative. 
Oral Abstract – UBC Department of Medicine Resident Research Day – June 2021 
 
Roland K, Isac G, Markin T, Lee F, Marcon K, Hudoba M. “Reducing unnecessary WBC differentials and slide reviews on ICU blood orders.” 
Abstract – Choosing Wisely Canada Virtual National Meeting – 2020
 
Marcon K, Chen K, Zhang XY, Shih A, Roland K, Smith T. “Impact of pre-printed order implementation for prothrombin complex concentrates: a quality assurance audit.”          
Oral Abstract – AABB Annual Meeting – Boston, MA – October 2018                      
Oral Abstract – UBC Pathology Day – Vancouver, BC – May 2018

Research Interest

  • Blood research
  • Quality Improvement and Assurance, Utilization Management

Teaching Interest

  • General Hematopathology
  • BMLSc
  • Hematology Fellows
  • Hematopathology Residents